Kyeoung Cheol Kim

Dr. Kyeoung Cheol Kim

orcid

Research Focus & Metrics

Representative Publications

View All Publications
3 April 2025 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
Muhammad Awais FarooqiMuhammad Awais Farooqi
Muhammad Awais Farooqi
JKJi-Hyang Kim
Ji-Hyang Kim
SKSehui Kim
Sehui Kim
KKKyeoung Cheol Kim
Kyeoung Cheol Kim
HFHafiz Muhammad Umer Farooqi
Hafiz Muhammad Umer Farooqi
CKChul-Ung Kang
Chul-Ung Kang


31 October 2021 in Korean Journal of Medicinal Crop Science
Verified
Journal Article
Closed access
KKKyeoung Cheol Kim
Kyeoung Cheol Kim
JKJu-Sung Kim
Ju-Sung Kim
Background: Many Artemisia species are used in traditional medicine to treat gastrointestinal disorders and various other ailments. However, the antioxidant and phenolic compounds present in Hallasan wormwood (Artemisia japonica var. hallaisanensis) have not been investigated yet. Methods and Results: Extracts of Hallasan wormwood (aerial parts and roots) were extracted using methanol and sequentially treated with solvent-solvent fractionation using n-hexane, ethyl acetate, and water-saturated butanol, to yield fractions with variations in polarity. The phenolic compounds present in the extracts and fractions were determined using high performance liquid chromatography (HPLC) and colorimetry. The antioxidant activities were determined using 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, trolox equivalent antioxidant capacity (TEAC), ferric reducing antioxidant power (FRAP), and oxygen radical antioxidant capacity (ORAC) methods. The results revealed that the ethyl acetate fraction had high total phenolic and total flavonoid contents. Furthermore, the ethyl acetate fraction of roots showed the highest antioxidant activity. Conclusions: Metanolic extracts from the roots and aerial parts of Hallasan wormwood showed different antioxidant activities; nine phenolic acids and one flavonoid were detected in Hallasan wormwood. Thus, the finding of this study provide valuable data for research on functional substances from plants.

10 February 2026 in Cell Stress and Chaperones
Verified
Journal Article
Open access
RPRambukkana Maggonage Thiruni Dananjana Perera
Rambukkana Maggonage Thiruni Dananjana Perera
SKSu-Lim Kim
Su-Lim Kim
JKJi-Hyang Kim
Ji-Hyang Kim
KKKyeoung Cheol Kim
Kyeoung Cheol Kim
DLDongsun Lee
Dongsun Lee
Autophagy and mitophagy are essential survival mechanisms that enable cancer cells to adapt to metabolic stress, particularly during nutrient deprivation. Therefore, targeting these pathways presents a promising therapeutic strategy. Thus, this study aimed to investigate the potential of isopimaric acid (IPA), a diterpenoid compound derived from Torreya nucifera, to disrupt autophagy-related processes in colon cancer cells. Notably, IPA treatment promoted the accumulation of autophagosomes, as indicated by increased LC3-II and p62 protein levels, suggesting an inhibition of autophagic flux rather than an enhancement of initiation. Further analysis revealed that IPA impaired lysosomal function and blocked autophagosome degradation. IPA also suppressed mitophagy by downregulating key regulators, including PINK1 and Parkin, resulting in mitochondrial dysfunction and the accumulation of reactive oxygen species (ROS). Particularly, IPA was non-toxic under nutrient-rich conditions but induced significant cell death under serum starvation conditions. To our knowledge, these findings are the first to show that IPA selectively induces apoptotic cell death in nutrient-deprived colon cancer cells by disrupting both late-stage autophagy and PINK1/Parkin-mediated mitophagy. Furthermore, this research establishes the development of innovative therapeutic strategies that specifically target metabolic stress and combination therapy.

28 October 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
TPThiruni Dananjana Perera
Thiruni Dananjana Perera
SKSu-Lim Kim
Su-Lim Kim
JKJi-Hyang Kim
Ji-Hyang Kim
KKKyeoung Cheol Kim
Kyeoung Cheol Kim
KTKang-Ui Tak
Kang-Ui Tak
DLDongsun Lee
Dongsun Lee
Background/Objectives: Colorectal cancer (CRC) remains a major contributor to cancer-associated deaths globally. Carica papaya L., a tropical fruit species, is reported to contain a wide range of biological properties, along with potential anticancer effects. However, studies evaluating the therapeutic potential and molecular mechanisms of Korean Carica papaya L. cultivars against CRC are limited. Therefore, this study investigated the effect of the hexane fraction of Carica papaya L. on the induction of apoptosis and the underlying mechanisms associated with this effect in human CRC cells. Methods: We performed several in vitro experiments, including cell viability, apoptosis, assessment of autophagic vacuoles, Western blotting, and analysis of autophagic flux. Subsequently, we verified the findings in an animal model of CRC induced by azoxymethane/dextran sulfate sodium. Results: BR 56 Hex F reduced cell viability and induced caspase-7/9-dependent apoptosis accompanied by intracellular and mitochondrial reactive oxygen species elevation. Mechanistically, BR 56 Hex F suppressed phosphatidylinositol 3-kinase (PI3K; p85/p110), p-AKT (Ser473/Thr308), and mammalian target of rapamycin signaling. Although autophagosome formation was initiated, the late-stage autophagic flux was impaired, as evidenced by p62 accumulation, LAMP-1 depletion, and autophagosome accumulation. In vivo, oral administration of BR 56 C. papaya L. extract significantly attenuated azoxymethane/dextran sulfate sodium-induced colon shortening, splenomegaly, histopathological damage, and colonic PI3K and p-AKT expression. Conclusions: BR 56 Hex F inhibited CRC growth by suppressing PI3K/AKT signaling and impairing late-stage autophagic flux, representing a potential natural candidate for CRC treatment.

Verified
Journal Article
Open access
PDF file
HKHiruni Sandunika Kumarasinghe
Hiruni Sandunika Kumarasinghe
DLDucDat Le
DucDat Le
JKJi-Hyang Kim
Ji-Hyang Kim
SKSu-Lim Kim
Su-Lim Kim
KKKyeoung Cheol Kim
Kyeoung Cheol Kim
DLDongsun Lee
Dongsun Lee
Triple-negative breast cancer (TNBC) is highly aggressive and lacks targeted therapies. This study investigated the anti-cancer mechanisms of sinapaldehyde (SNAH). The biological effects of SNAH were evaluated in vitro using MDA-MB-231 TNBC cells. Cellular responses, including autophagy, mitochondrial function, apoptosis, cell-cycle progression, migration, and colony formation were investigated. In silico studies explored associated regulatory networks and binding targets. Sinapaldehyde (SNAH) treatment was associated with mitochondrial dysfunction, characterized by alterations in mitochondrial structural and functional markers, increased reactive oxygen species(ROS) production, and loss of mitochondrial membrane potential. SNAH treatment also altered the expression of PINK1 and Parkin and modulated autophagy-associated markers, including LC3B, p62, LAMP1, Beclin-1, and ATG proteins. Time-dependent changes in autophagy- and apoptosis-associated markers were accompanied by increased Annexin V-positive cells and activation of cleaved caspase-9 and caspase-3. SNAH also altered FTH1 and NCOA4 expression, suggesting modulation of ferritinophagy-associated processes, and inhibited migration and colony formation while inducing G2/M cell-cycle arrest. In silico analyses identified potential breast cancer-related molecular targets and signaling pathways associated with SNAH. SNAH induces mitochondrial dysfunction and is associated with alterations in autophagy/mitophagy-associated signaling and activation of apoptosis in MDA-MB-231 TNBC cells. These findings provide insight into the cellular responses to SNAH treatment, while further functional studies are required to establish changes in mitophagic and ferritinophagic flux and the causal relationship between autophagy and apoptosis.